Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124568373 | 12456837 | 3 | F | 20160213 | 20160712 | 20160610 | 20160720 | EXP | RO-KADMON PHARMACEUTICALS, LLC-KAD201606-002124 | KADMON | 73.43 | YR | M | Y | 65.00000 | KG | 20160720 | MD | RO | RO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124568373 | 12456837 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | FILM-COATED TABLET | Y | 77456 | FILM-COATED TABLET | ||||||||
| 124568373 | 12456837 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 77456 | 800 | MG | ||||||||
| 124568373 | 12456837 | 3 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 77456 | 1000 | MG | ||||||||
| 124568373 | 12456837 | 4 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 77456 | 800 | MG | ||||||||
| 124568373 | 12456837 | 5 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | Oral | Y | 77456 | 1000 | MG | ||||||||
| 124568373 | 12456837 | 6 | SS | Viekirax | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | Oral | FILM-COATED TABLET | 0 | FILM-COATED TABLET | |||||||||
| 124568373 | 12456837 | 7 | SS | Viekirax | OMBITASVIRPARITAPREVIRRITONAVIR | 1 | 0 | ||||||||||||
| 124568373 | 12456837 | 8 | SS | Exviera | DASABUVIR | 1 | Oral | FILM-COATED TABLET | 0 | FILM-COATED TABLET | |||||||||
| 124568373 | 12456837 | 9 | SS | Exviera | DASABUVIR | 1 | 0 | ||||||||||||
| 124568373 | 12456837 | 10 | C | SOTALOL. | SOTALOL | 1 | Oral | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124568373 | 12456837 | 1 | Hepatitis C |
| 124568373 | 12456837 | 2 | Hepatic cirrhosis |
| 124568373 | 12456837 | 6 | Hepatitis C |
| 124568373 | 12456837 | 7 | Hepatic cirrhosis |
| 124568373 | 12456837 | 8 | Hepatitis C |
| 124568373 | 12456837 | 9 | Hepatic cirrhosis |
| 124568373 | 12456837 | 10 | Cardiac disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124568373 | 12456837 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124568373 | 12456837 | Abdominal pain | |
| 124568373 | 12456837 | Atrial fibrillation | |
| 124568373 | 12456837 | Burn oesophageal | |
| 124568373 | 12456837 | Diarrhoea | |
| 124568373 | 12456837 | Headache | |
| 124568373 | 12456837 | Jaundice | |
| 124568373 | 12456837 | Malaise | |
| 124568373 | 12456837 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124568373 | 12456837 | 1 | 20160213 | 20160221 | 0 | |
| 124568373 | 12456837 | 2 | 20160224 | 20160227 | 0 | |
| 124568373 | 12456837 | 3 | 20160228 | 20160422 | 0 | |
| 124568373 | 12456837 | 4 | 20160426 | 20160430 | 0 | |
| 124568373 | 12456837 | 5 | 20160501 | 20160507 | 0 | |
| 124568373 | 12456837 | 6 | 20160213 | 20160507 | 0 | |
| 124568373 | 12456837 | 8 | 20160213 | 20160507 | 0 | |
| 124568373 | 12456837 | 10 | 20151101 | 0 |